Cigna EPS (Diluted) increased by 34.9% to $6.26 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.1%, from $4.85 to $6.26. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 9.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.25 | $4.80 | $3.38 | $3.68 | $4.90 | $8.97 | $3.75 | $4.24 | $4.92 | $4.74 | $3.49 | -$0.97 | $5.45 | $2.63 | $5.01 | $4.85 | $5.71 | $6.98 | $4.64 | $6.26 |
| QoQ Change | — | +12.9% | -29.6% | +8.9% | +33.2% | +83.1% | -58.2% | +13.1% | +16.0% | -3.7% | -26.4% | -127.8% | +661.9% | -51.7% | +90.5% | -3.2% | +17.7% | +22.2% | -33.5% | +34.9% |
| YoY Change | — | — | — | — | +15.3% | +86.9% | +10.9% | +15.2% | +0.4% | -47.2% | -6.9% | -122.9% | +10.8% | -44.5% | +43.6% | +600.0% | +4.8% | +165.4% | -7.4% | +29.1% |